· February 11, 2010 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
· February 11, 2010 3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial
· February 11, 2010 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
· February 8, 2010 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil® for Hyperphosphatemia